<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00984958</url>
  </required_header>
  <id_info>
    <org_study_id>Bulkamid ISD2009 04</org_study_id>
    <nct_id>NCT00984958</nct_id>
  </id_info>
  <brief_title>Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure</brief_title>
  <official_title>Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure Because of Suspected ISD: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skaraborg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Skaraborg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective, randomized study of Bulkamid treatment is to investigate the
      efficacy of Bulkamid treatment in women with urinary stress incontinence not suitable to
      TVT-procedure because of suspected ISD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this prospective, randomized study is to investigate the effect of Bulkamid
      injection for women with urinary stress incontinence and not suitable to TVT-procedure
      because of suspected ISD and compare this treatment with no or traditional treatment. The
      primary endpoint for efficacy will be reduction of leakage during pad-test at 2 months
      compared with pad- test before injection.

      Secondary endpoints will be patient satisfaction measured at both 2 and 12 months using a
      questionnaire and the number of side effects.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>After 2 months a scheduled visit with a new pad-test will be performed and the questionnaires UDI-6 (lover urinary tract symptoms) and IIQ-7 (quality of life) will be filled in.</measure>
    <time_frame>2 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>After 12 months a scheduled visit with new pad-test will be performed and the questionnaires UDI-6 (lover urinary tract symptoms) and IIQ-7 (quality of life) will be filled in.</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Urinary Stress Incontinence</condition>
  <condition>Treatment</condition>
  <arm_group>
    <arm_group_label>Bulkamid</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Injection with Bulkamid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>expectance</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The expectance arm will after 2 month have the same treatment as the treatment arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bulkamid</intervention_name>
    <description>injection of Bulkamid in the urethra</description>
    <arm_group_label>Bulkamid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bulkamid expectation</intervention_name>
    <description>expectance</description>
    <arm_group_label>expectance</arm_group_label>
    <other_name>after 2 month the patient can be treated</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Ability to understand the information and to give informed consent.

          -  At least 50 years of age

          -  History of urinary leakage during low grade physical activity. A woman with genuine
             stress incontinence has urinary incontinence during running or jumping. Women with
             suspected ISD have incontinence at much lower grade of physical activity such as slow
             walking or standing up and just coughing. Walking, standing up from a chair, and
             coughing are regarded as low grade of physical activity.

          -  A positive pad-test (after coughing 10 times) with increase of minimum of 10 grams of
             urine with 300 ml in the bladder or a 24 h pad-test of more than 100 mg of urine

          -  No hypermobility of the urethra during cough test.

          -  Low pressure of the urethra (optional?)

          -  With a of average miction volume of minimum 150 ml and at least one volume of more
             than 250

        Exclusion Criteria:

          -  Women with hypermobility of the urethra during coughing and positive Bonney's test

          -  Women suitable for a TVT procedure.

          -  Positive urinary culture

          -  Urge incontinence
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P-G Larsson, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departm Ob/Gyn Kärnsjukhuset, 541 85 SKövde, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>P-G B Larsson, professor</last_name>
    <phone>+46500431445</phone>
    <email>p-g.larsson@vgregion.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Deprtm Ob/Gyn Östra Sjukhuset Sahlgrenska</name>
      <address>
        <city>Göteborg</city>
        <zip>41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne Pedroletti</last_name>
    </contact>
    <investigator>
      <last_name>Corinne Pedroletti, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deprtm Ob/Gyn</name>
      <address>
        <city>Skövde</city>
        <zip>SE54185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P-G Larsson, professor</last_name>
      <phone>+46500431445</phone>
      <email>p-g.larsson@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>P-G Larsson, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deprtm Ob/Gyn Huddinge</name>
      <address>
        <city>Stockholm</city>
        <zip>11883</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunilla Tegerstedt, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Gunilla Tegerstedt, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deprtm Ob/Gyn, NU sjukvården</name>
      <address>
        <city>Trollhättan</city>
        <zip>46185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingegred Olsson, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Ingegerd Olssson, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2009</study_first_submitted>
  <study_first_submitted_qc>September 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2009</study_first_posted>
  <last_update_submitted>November 20, 2014</last_update_submitted>
  <last_update_submitted_qc>November 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Skaraborg Hospital</investigator_affiliation>
    <investigator_full_name>Per-Goran Larsson</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

